BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

869 related articles for article (PubMed ID: 25639313)

  • 1. Cushing's disease: current medical therapies and molecular insights guiding future therapies.
    Lau D; Rutledge C; Aghi MK
    Neurosurg Focus; 2015 Feb; 38(2):E11. PubMed ID: 25639313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cushing's disease.
    Tritos NA; Biller BM
    Handb Clin Neurol; 2014; 124():221-34. PubMed ID: 25248590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New avenues in the medical treatment of Cushing's disease: corticotroph tumor targeted therapy.
    Fleseriu M; Petersenn S
    J Neurooncol; 2013 Aug; 114(1):1-11. PubMed ID: 23673515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medical Treatment of Cushing's Disease: An Overview of the Current and Recent Clinical Trials.
    Pivonello R; Ferrigno R; De Martino MC; Simeoli C; Di Paola N; Pivonello C; Barba L; Negri M; De Angelis C; Colao A
    Front Endocrinol (Lausanne); 2020; 11():648. PubMed ID: 33363514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs in the medical treatment of Cushing's syndrome.
    Schteingart DE
    Expert Opin Emerg Drugs; 2009 Dec; 14(4):661-71. PubMed ID: 19939210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical treatment of Cushing's disease: somatostatin analogues and pasireotide.
    Pedroncelli AM
    Neuroendocrinology; 2010; 92 Suppl 1():120-4. PubMed ID: 20829632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Treatment of Cushing's Disease.
    Pivonello R; De Leo M; Cozzolino A; Colao A
    Endocr Rev; 2015 Aug; 36(4):385-486. PubMed ID: 26067718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical therapy of Cushing's disease: where are we now?
    Alexandraki KI; Grossman AB
    Front Horm Res; 2010; 38():165-173. PubMed ID: 20616508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical treatment of Cushing's disease.
    Feelders RA; Hofland LJ
    J Clin Endocrinol Metab; 2013 Feb; 98(2):425-38. PubMed ID: 23345100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of Cushing's disease - from investigation to treatment.
    Juszczak A; Grossman A
    Endokrynol Pol; 2013; 64(2):166-74. PubMed ID: 23653280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatostatin and somatostatin receptors in Cushing's disease.
    Hofland LJ
    Mol Cell Endocrinol; 2008 May; 286(1-2):199-205. PubMed ID: 18221833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in medical therapies for Cushing's syndrome.
    Tritos NA; Biller BM
    Discov Med; 2012 Feb; 13(69):171-9. PubMed ID: 22369976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial.
    Boscaro M; Ludlam WH; Atkinson B; Glusman JE; Petersenn S; Reincke M; Snyder P; Tabarin A; Biller BM; Findling J; Melmed S; Darby CH; Hu K; Wang Y; Freda PU; Grossman AB; Frohman LA; Bertherat J
    J Clin Endocrinol Metab; 2009 Jan; 94(1):115-22. PubMed ID: 18957506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical therapy for Cushing's disease: adrenal steroidogenesis inhibitors and glucocorticoid receptor blockers.
    Fleseriu M; Petersenn S
    Pituitary; 2015 Apr; 18(2):245-52. PubMed ID: 25560275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pasireotide: a review of its use in Cushing's disease.
    McKeage K
    Drugs; 2013 May; 73(6):563-74. PubMed ID: 23605695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome.
    Kamenický P; Droumaguet C; Salenave S; Blanchard A; Jublanc C; Gautier JF; Brailly-Tabard S; Leboulleux S; Schlumberger M; Baudin E; Chanson P; Young J
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2796-804. PubMed ID: 21752886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical management of critically ill patients with Cushing's disease due to ACTH-secreting pituitary macroadenomas: effectiveness of presurgical treatment with pasireotide.
    Cannavo S; Messina E; Albani A; Ferrau F; Barresi V; Priola S; Esposito F; Angileri F
    Endocrine; 2016 Jun; 52(3):481-7. PubMed ID: 25877016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential role for retinoic acid in patients with Cushing's disease.
    Pecori Giraldi F; Ambrogio AG; Andrioli M; Sanguin F; Karamouzis I; Corsello SM; Scaroni C; Arvat E; Pontecorvi A; Cavagnini F
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3577-83. PubMed ID: 22851491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of medical treatment in Cushing's disease: a systematic review.
    Gadelha MR; Vieira Neto L
    Clin Endocrinol (Oxf); 2014 Jan; 80(1):1-12. PubMed ID: 24118077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis.
    Invitti C; Pecori Giraldi F; de Martin M; Cavagnini F
    J Clin Endocrinol Metab; 1999 Feb; 84(2):440-8. PubMed ID: 10022398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 44.